Automation of oncoReveal Solid Tumor 22 Gene Panel and the Illumina TruSight Oncology 500 DNA/RNA
Beckman Coulter Life Sciences automated both Pillar's oncoReveal® Solid Tumor 22 Gene Panel and Illumina's TruSight Oncology 500 DNA/RNA kit on the Biomek NGeniuS library preparation system to reduce manual pipetting and hands-on time. Three test runs per assay used engineered controls including Horizon Discovery fcDNA and SeraSeq® reference standards, sequenced on Illumina MiSeq and NextSeq 500 and analyzed with PiVAT® and DRAGEN. The Pillar panel reached sequencing by the end of day one at batch sizes from 4 to 24 samples, while the 523-gene TSO500 workflow ran into day three.
